close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

Home・Aandelen Lijst・Merck KGaA
Search

Merck KGaA

Open

SectorGezondheidszorg

111.85 -2.91

Buy

Prijsupdate 18 nov 2025, 13:40 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

111.25

Max

115.9

Belangrijke statistieken

By Trading Economics

Inkomsten

-83M

652M

Verkoop

-25M

5.3B

EPS

2.07

Dividendrendement

1.34

Winstmarge

12.407

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+17.72% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.34%

2.37%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

98B

Vorige openingsprijs

114.76

Vorige sluitingsprijs

111.85

Nieuwssentiment

By Acuity

24%

76%

55 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bearish Evidence

121.15 / 123.55 Steun & Weerstand

Merck KGaA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 nov 2025, 13:40 UTC

Winsten

Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update

DJ

Lezen

13 nov 2025, 06:24 UTC

Winsten

Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units

DJ

Lezen

1 okt 2025, 08:54 UTC

Belangrijke Marktbewegers

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

DJ

Lezen

13 nov 2025, 07:57 UTC

Marktinformatie
Winsten

Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA Says Guidance Midpoint Remains Unchanged

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA Sees 2025 Organic Sales Growth of Around 3%

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA 3Q After-Tax Profit EUR898M

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA Narrows 2025 View

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Analysts Saw Merck KGaA 3Q Net Sales at EUR5.23B

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.67B

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Analysts Saw Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.56B

DJ

Lezen

13 nov 2025, 06:00 UTC

Winsten

Merck KGaA 3Q Sales EUR5.32B

DJ

Lezen

6 nov 2025, 21:52 UTC

Acquisities, Fusies, Overnames

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

DJ

Lezen

6 nov 2025, 21:51 UTC

Acquisities, Fusies, Overnames

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

DJ

Lezen

16 okt 2025, 08:34 UTC

Marktinformatie

Merck KGaA's Cost Cutting Likely Led to Profitability Target Raise -- Market Talk

DJ

Lezen

15 okt 2025, 12:08 UTC

Acquisities, Fusies, Overnames

Merck KGaA Didn't Disclose Financial Details

DJ

Lezen

15 okt 2025, 12:07 UTC

Acquisities, Fusies, Overnames

Merck KGaA: JSR's Amsphere Protein A Resin Tech Complements Existing Biologics Portfolio

DJ

Lezen

15 okt 2025, 12:07 UTC

Acquisities, Fusies, Overnames

Merck KGaA: Unit is Based in Belgium, Has 50+ Employees

DJ

Lezen

15 okt 2025, 12:06 UTC

Acquisities, Fusies, Overnames

Merck KGaA: Deal Will Strengthen Position in Bioprocessing Market

DJ

Lezen

15 okt 2025, 12:05 UTC

Acquisities, Fusies, Overnames

Merck KGaA: Definitive Agreement Signed Today

DJ

Lezen

15 okt 2025, 12:05 UTC

Acquisities, Fusies, Overnames

Merck KGaA: Transaction Expected to Close by End of 2Q 2026

DJ

Lezen

15 okt 2025, 12:04 UTC

Acquisities, Fusies, Overnames

Merck KGaA to Buy Chromatography Business JSR Life Sciences

DJ

Lezen

15 okt 2025, 12:03 UTC

Acquisities, Fusies, Overnames

Merck KGaA to Buy Chromatography Business of JSR Life Sciences

DJ

Lezen

7 aug 2025, 08:04 UTC

Marktinformatie
Winsten

Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

Merck KGaA Prognose

Koersdoel

By TipRanks

17.72% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 138.38 EUR  17.72%

Hoogste 182 EUR

Laagste 105 EUR

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Merck KGaA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

5

Buy

3

Hold

1

Sell

Gebaseerd op 9 analisten die aandelenratings hebben gegeven aan Merck KGaA - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

121.15 / 123.55Steun & Weerstand

Korte Termijn

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Neutral Evidence

The bullish and bearish events are balanced.

Lange Termijn

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

55 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Merck KGaA

There is no Profile data available for MRK.BE.

Andere aandelen uit de sector

QDEL

Quidel Corp

21.01

↓-1.5%

NERV

Minerva Neurosciences Inc

4.3

↑ +5.91%

LSTA.US

Lisata Therapeutics

2.02

↓-4.72%
help-icon Live chat